ATAI
ATAI Life Sciences BV
NASDAQ: ATAI · HEALTHCARE · BIOTECHNOLOGY
$4.12
-4.85% today
Updated 2026-04-29
Market cap
$1.51B
P/E ratio
—
P/S ratio
369.70x
EPS (TTM)
$-2.91
Dividend yield
—
52W range
$1 – $7
Volume
6.2M
ATAI Life Sciences BV (ATAI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,588.00%
ROE
-390.00%
ROA
-30.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-14.14M | — | — | — |
| 2020 | $19.88M | $-169.84M | -0.12% | -523.95% | -854.34% |
| 2021 | $20.38M | $-167.81M | 100.00% | -666.49% | -823.56% |
| 2022 | $233000.00 | $-152.38M | 100.00% | -62,140.34% | -65,401.29% |
| 2023 | $314000.00 | $-40.22M | 100.00% | -39,958.92% | -12,810.19% |
| 2024 | $308000.00 | $-149.27M | 100.00% | -33,341.23% | -48,463.96% |
| 2025 | $4.09M | $-660.05M | 75.25% | -2,789.46% | -16,142.02% |